
LeaseAccounting.app is the self-serve IFRS 16 and FRS 102 lease accounting platform built for SME finance teams that need audit-ready compliance without
spreadsheets, implementation consultants, or six-figure software contracts. Made by ZenTreasury Oy in Helsinki, Finland with EU-only data hosting. Who it's for: group controllers, finance managers, and CFOs at companies reporting under IFRS 16, FRS 102 (UK GAAP), and ASC 842 (coming soon), typically managing 5 to 50 leases across 1 to 10 entities. Core workflow: upload your lease contracts; AI-assisted contract extraction reads each PDF and proposes around 25 fields with confidence scoring; you review and approve; the deterministic calculation engine produces the right-of-use asset, lease liability, journal entries, schedules, modifications, remeasurements, and indexation entries automatically. Same inputs, same outputs, every time. Zen AI is advisory only and never touches a calculation. Capabilities include: Discount Rate Advisor (reference rates from central bank sources, AI drafts the rate memo for review), continuous compliance monitoring (flags indexations due, expiring leases, and overdue reassessments daily), multi-entity bookkeeping from day one, one-click audit evidence packs that auditors can verify independently, and auditor portal access with activity logging (coming soon). Integrations: journal export to SAP (BKPF/BSEG), Oracle (FBDI), Microsoft Dynamics, and NetSuite formats. Azure AD / Entra ID SSO with JIT provisioning and domain verification. Live Sage Intacct API integration in development. Pricing: free tier covers 2 leases with no credit card required. Starter €149, Growth €349, Pro €699 per month, with no per-seat pricing and generous team access included on every tier. Built IFRS-first, EU-hosted, and fully self-serve. The alternative to spreadsheet chaos and consultant-heavy enterprise lease tools.
Learn more

A cloud-based Laboratory Information Management System (LIMS) is designed to oversee sample tracking, test outcomes, and inventory management specifically for life sciences research, industrial quality control laboratories, and biotechnology/next-generation sequencing applications. This comprehensive system provides essential regulatory compliance support for standards such as CLIA, HIPAA, Part 11, and ISO 17025, ensuring that laboratories operate within the necessary legal frameworks. The importance of quality, security, and traceability in managing samples cannot be overstated, as these factors play a pivotal role in a lab's effectiveness and reliability. Utilizing the Lockbox LIMS platform, laboratory professionals gain the ability to meticulously oversee their samples, offering complete transparency throughout the entire process, from initial accession to long-term preservation. Additionally, LIMS analysis encompasses far more than merely tracking outcomes; the Lockbox system features advanced multilayered sample storage capabilities and location management, allowing users to customize their laboratory's storage framework with diverse options that include rooms, storage units, shelves, racks, and boxes. This flexibility empowers labs to efficiently organize and access their samples, ultimately enhancing operational productivity and accuracy.
Learn more
Springer
Springer is recognized as a leading international entity in scientific, technical, and medical publishing, delivering premium content to academics, scientific institutions, and corporate research teams through innovative information products and services. With a vast assortment of eBooks covering STM and HSS disciplines, alongside a wide range of hybrid and open access journals and books published under the SpringerOpen label, Springer effectively meets the information demands of the global research community. As an integral part of Springer Nature, a major global publishing organization, Springer is committed to promoting the progression of research by sharing valuable scientific insights, encouraging the investigation of new research fields, and ensuring that knowledge is readily available worldwide. By focusing on the requirements of researchers and academic institutions, Springer plays a crucial role in fostering ongoing dialogue and advancement within the scientific arena. This commitment not only enhances the dissemination of knowledge but also strengthens collaborations across various research disciplines.
Learn more
Embase
Elevate your biomedical research pursuits by tapping into the world's most expansive database of biomedical literature. With a comprehensive and up-to-date search methodology, you gain access to a vast reservoir of relevant biomedical evidence. Simplify your systematic searches with automated query generation, which is made easy through intuitive search forms. Unearth vital insights regarding drug-disease interactions and drug-drug relationships, all meticulously compiled through diligent indexing efforts. The swift advancements in biomedical research and development underline the importance of having extensive information at your fingertips to assess potential risks by reviewing all available data. Additionally, you can track safety standards to ensure regulatory compliance while uncovering connections that drive innovation. Embase is unparalleled as a medical literature database, emphasizing depth of information over mere quantity. The Emtree indexing of full-text resources and specialized search terminology empowers you to discover all critical and current information, including data that might be overlooked by other databases. As you explore further, you'll find compelling reasons why regulatory bodies recommend Embase in their best practice guidelines, making sure your research is both comprehensive and aligned with industry standards. This dedication to providing superior biomedical literature solidifies Embase's role as an essential resource for both researchers and practitioners, fostering an environment of informed decision-making and innovation in the field. By integrating Embase into your research toolkit, you not only enhance the quality of your work but also contribute to the broader scientific community's understanding of complex biomedical issues.
Learn more